• May 5, 2021

VivaDiag SARS-CoV-2 Ag Rapid Test

The VivaDiag ™ SARS-CoV-2 Ag Rapid Test is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal swabs or oropharyngeal swabs. The test is for in vitro diagnostic use only.

The VivaDiag ™ SARS-CoV-2 Ag Rapid Test is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal swabs or oropharyngeal swabs from individuals suspected of COVID-19. Nucleocapsid protein antigen test results should not be used as the sole basis for diagnosing or excluding SARS-CoV-2 (COVID-19) infection or for reporting infection status.

Leave a Reply

Your email address will not be published.